Home LiteratureArticle Details
PMID: 3963561 Published · ppublish English Journal Article

Heterotransplantation of equine carcinoma cells in athymic (nude) mice.

American journal of veterinary research ·Vol. 47 ·No. 3 ·1986-03-00 ·Pages 610-4

Pardini LL, Aaronson LM, Hering PL, Pardini RS

Abstract

Nondifferentiated equine carcinoma cells from a primary lesion were implanted subcutaneously in athymic (nude) mice. The cells were implanted at 2 sites each in 3 mice. At 1 of the 6 inoculation sites, a tumor developed, which invaded surrounding tissues, as shown by histopathologic examination. Karyotype analysis verified that the tumor was of equine origin. Cells from this tumor were serially heterotransplanted 20 times without change in growth rate. Once established in nude mice, this equine carcinoma cell line was stored cryogenically and then was successfully reimplanted into nude mice. All of the implants developed into tumors, over 20 generations. Preliminary screening of antineoplastic drugs indicated that this tumor line is sensitive to cyclophosphamide. Because of its ease of handling and high reimplantation efficiency, this tumor line should prove useful in equine cancer research.

MeSH Terms
Animals Cell Division Cell Line Female Horse Diseases/pathology Horses Karyotyping Male Mice Mice, Nude Neoplasm Transplantation Skin Neoplasms/pathology,veterinary Transplantation, Heterologous
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Pardini L L
Aaronson L M
Hering P L
Pardini R S
Article Info
Journal
American journal of veterinary research
Abbr.
Am J Vet Res
ISSN
0002-9645
Published
1986-03-00
Pages
610-4
Language
English
Region
United States
NLM ID
0375011
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]